| Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities MSY J. Akhtar, A. A. Khan, Z. Ali, R. Haider Eur. J. Med. Chem 125, 143-189, 2017 | 511 | 2017 |
| Antidepressant Potential of Nitrogen containing Heterocyclic Moieties: An updated review RK N. Siddiqui, Andalip, S. Bawa, R. Ali, O. Afzal, M. J. Akhtar, B. Azad J. Pharm. Bioallied. Sci 3, 194-212, 2011 | 120 | 2011 |
| Design, synthesis, docking and QSAR study of substituted benzimidazole linked oxadiazole as cytotoxic agents, EGFR and erbB2 receptor inhibitors MSY M. J. Akhtar, A. A. Siddiqui, A. A. Khan, Z Ali, R. P. Dewangan, S. Pasha Eur. J. Med. Chem 126, 853-869, 2017 | 118 | 2017 |
| Isatin containing heterocycles for different biological activities: Analysis of structure activity relationship R Nath, S Pathania, G Grover, MJ Akhtar Journal of Molecular Structure 1222, 128900, 2020 | 102 | 2020 |
| Insights into the structure activity relationship of nitrogen-containing heterocyclics for the development of antidepressant compounds: An updated review K Singh, R Pal, SA Khan, B Kumar, MJ Akhtar Journal of Molecular Structure 1237, 130369, 2021 | 95 | 2021 |
| Current perspectives on quinazolines with potent biological activities: A review T Gupta, A Rohilla, A Pathak, MJ Akhtar, MR Haider, MS Yar Synthetic Communications 48 (10), 1099-1127, 2018 | 95 | 2018 |
| Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors MJ Akhtar, AA Khan, Z Ali, RP Dewangan, M Rafi, MQ Hassan, MS Akhtar, ... Bioorganic Chemistry 78, 158-169, 2018 | 94 | 2018 |
| The growing concern of chlorpyrifos exposures on human and environmental health NK Nandi, A Vyas, MJ Akhtar, B Kumar Pesticide biochemistry and physiology 185, 105138, 2022 | 87 | 2022 |
| Triazoles: as potential bioactive agents N Siddiqui, W Ahsan, MS Alam, R Ali, S Jain, B Azad, J Akhtar Int. J. Pharm. Sci. Rev. Res 8, 161-169, 2011 | 76 | 2011 |
| Recent progress of benzimidazole hybrids for anticancer potential MJ Akhtar, MS Yar, VK Sharma, AA Khan, Z Ali, MDR Haider, A Pathak Current Medicinal Chemistry 27 (35), 5970-6014, 2020 | 59 | 2020 |
| Voltage gated sodium channel inhibitors as anticonvulsant drugs: A systematic review on recent developments and structure activity relationship studies R Pal, B Kumar, MJ Akhtar, PA Chawla Bioorganic Chemistry 115, 105230, 2021 | 55 | 2021 |
| Piperazine, a key substructure for antidepressants: Its role in developments and structure‐activity relationships RR Kumar, B Sahu, S Pathania, PK Singh, MJ Akhtar, B Kumar ChemMedChem 16 (12), 1878-1901, 2021 | 53 | 2021 |
| DYRK1A kinase inhibition with emphasis on neurodegeneration: A comprehensive evolution story-cum-perspective A Pathak, A Rohilla, T Gupta, MJ Akhtar, MR Haider, K Sharma, K Haider, ... European journal of medicinal chemistry 158, 559-592, 2018 | 53 | 2018 |
| Synthetic and therapeutic perspectives of nitrogen containing heterocycles as anti-convulsants G Grover, R Nath, R Bhatia, MJ Akhtar Bioorganic & Medicinal Chemistry 28 (15), 115585, 2020 | 51 | 2020 |
| Coumarin linked heterocyclic hybrids: a promising approach to develop multi target drugs for Alzheimer's disease A Husain, K Al Balushi, MJ Akhtar, SA Khan Journal of Molecular Structure 1241, 130618, 2021 | 48 | 2021 |
| Formulation and evaluation of nano lipid formulation containing CNS acting drug: molecular docking, in-vitro assessment and bioactivity detail in rats M Alam, AK Najmi, I Ahmad, FJ Ahmad, MJ Akhtar, SS Imam, M Akhtar Artificial cells, nanomedicine, and biotechnology 46 (sup2), 46-57, 2018 | 48 | 2018 |
| Rosuvastatin Attenuates High-Salt and Cholesterol Diet Induced Neuroinflammation and Cognitive Impairment via Preventing Nuclear Factor KappaB Pathway AKN I. Hussain, M. Akhtar, D. Vohora, M. Z. Abdin, M. Islamuddin, M. J. Akhtar Neurochem. Res, 2017 | 47 | 2017 |
| Synthesis of Novel Substituted Benzimidazole Derivatives As Potential Antimicrobial Agents HSL R. Walia, K. Dhamija, Vandana, M. J. Akhtar Int. J. Pharm. Chem. Bio. Sci 2, 293-298, 2012 | 45* | 2012 |
| Novel 9-(2-(1-arylethylidene)hydrazinyl)acridine derivatives: Target Topoisomerase 1 and growth inhibition of HeLa cancer cells md rafi bioorganic chemistry, 2019 | 41 | 2019 |
| Structural modification and strategies for the enhanced doxorubicin drug delivery SA Khan, MJ Akhtar Bioorganic Chemistry 120, 105599, 2022 | 38 | 2022 |
Mohammad Shahar Yar, ProfessorJamia HamdardE-mail megerősítve itt: jamiahamdard.ac.in
